• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝切除术后复发时间短与结直肠癌肝转移预后不良相关。

Short time to recurrence after hepatic resection correlates with poor prognosis in colorectal hepatic metastasis.

作者信息

Takahashi Shinichiro, Konishi Masaru, Nakagohri Toshio, Gotohda Naoto, Saito Norio, Kinoshita Taira

机构信息

Department of Surgery, National Cancer Center Hospital East, Kashiwa, Chiba 277-8577, Japan.

出版信息

Jpn J Clin Oncol. 2006 Jun;36(6):368-75. doi: 10.1093/jjco/hyl027. Epub 2006 Jun 8.

DOI:10.1093/jjco/hyl027
PMID:16762969
Abstract

BACKGROUND

Early recurrence is a major problem after hepatic resection of colorectal hepatic metastasis (CHM). Our aim was to investigate the relationship between time to recurrence after CHM resection and overall survival.

METHODS

A retrospective analysis was performed for 101 consecutive patients who underwent hepatic resection for CHM and have been followed more than 5 years.

RESULTS

Among 101 patients, 82 (81%) had a recurrence. Overall survival of patients with recurrence within 6 months after CHM resection was significantly worse than that of patients with recurrence after more than 6 months (P < 0.01). Overall survival was poorer when time to recurrence was shorter. One of the reasons for poor prognosis of patients with recurrence within 6 months was that only a few patients could undergo a second resection for recurrence after CHM resection. Histological type, including poorly differentiated signet ring cell or mucinous adenocarcinoma in the primary tumor, bilobar metastases, microscopic positive surgical margin and carcinoembryonic antigen (CEA) above 15 ng/ml had predictive value for decreased recurrence-free survival after CHM resection.

CONCLUSION

Short time to recurrence after CHM resection correlates with a poor prognosis. Histological type of poorly differentiated signet ring cell or mucinous adenocarcinoma in the primary tumor might be a predictor for early recurrence after CHM resection.

摘要

背景

早期复发是结直肠癌肝转移(CHM)肝切除术后的一个主要问题。我们的目的是研究CHM切除术后复发时间与总生存期之间的关系。

方法

对101例连续接受CHM肝切除术且随访超过5年的患者进行回顾性分析。

结果

101例患者中,82例(81%)出现复发。CHM切除术后6个月内复发患者的总生存期明显差于6个月后复发的患者(P<0.01)。复发时间越短,总生存期越差。CHM切除术后6个月内复发患者预后不良的原因之一是只有少数患者能够接受复发后的二次切除。组织学类型,包括原发肿瘤中低分化印戒细胞或黏液腺癌、双叶转移、显微镜下手术切缘阳性以及癌胚抗原(CEA)高于15 ng/ml对CHM切除术后无复发生存期缩短具有预测价值。

结论

CHM切除术后复发时间短与预后不良相关。原发肿瘤中低分化印戒细胞或黏液腺癌的组织学类型可能是CHM切除术后早期复发的一个预测指标。

相似文献

1
Short time to recurrence after hepatic resection correlates with poor prognosis in colorectal hepatic metastasis.肝切除术后复发时间短与结直肠癌肝转移预后不良相关。
Jpn J Clin Oncol. 2006 Jun;36(6):368-75. doi: 10.1093/jjco/hyl027. Epub 2006 Jun 8.
2
Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis.显微镜下肝门淋巴结受累对结直肠癌肝转移切除术后生存的影响。
J Am Coll Surg. 2004 Jun;198(6):884-91. doi: 10.1016/j.jamcollsurg.2004.01.017.
3
Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions.结直肠癌肝转移的治疗结果:特别提及肝切除术的有效性——对18家机构记录的763例病例的预后因素分析
Dis Colon Rectum. 2003 Oct;46(10 Suppl):S22-31. doi: 10.1097/01.DCR.0000089106.71914.00.
4
Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience.手术切缘对结直肠癌肝转移灶切除术后复发类型的影响:单中心经验
Surgery. 2008 Mar;143(3):384-93. doi: 10.1016/j.surg.2007.09.038. Epub 2007 Dec 21.
5
Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery.根治性手术后结直肠癌异时性肝转移的射频消融治疗
Ann Surg Oncol. 2008 Jan;15(1):227-32. doi: 10.1245/s10434-007-9625-z. Epub 2007 Sep 20.
6
The relationship between prognosis and CEA-dt after hepatic resection in patients with colorectal carcinomas.结直肠癌患者肝切除术后预后与癌胚抗原倍增时间的关系。
Eur J Surg Oncol. 1999 Jun;25(3):292-6. doi: 10.1053/ejso.1998.0644.
7
[Univariate and multivariate regression analyses of recurrence and metastasis of colon cancer after radical resection].[结肠癌根治性切除术后复发和转移的单因素及多因素回归分析]
Ai Zheng. 2006 May;25(5):591-5.
8
Intrahepatic lymphatic invasion independently predicts poor survival and recurrences after hepatectomy in patients with colorectal carcinoma liver metastases.肝内淋巴浸润可独立预测结直肠癌肝转移患者肝切除术后的不良生存和复发情况。
Ann Surg Oncol. 2007 Dec;14(12):3472-80. doi: 10.1245/s10434-007-9594-2. Epub 2007 Sep 8.
9
Clinical significance of microvessel count in patients with metastatic liver cancer originating from colorectal carcinoma.结直肠癌肝转移患者微血管计数的临床意义
Ann Surg Oncol. 2009 Aug;16(8):2130-7. doi: 10.1245/s10434-009-0459-8. Epub 2009 Jun 4.
10
Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.结直肠癌根治术后血清癌胚抗原监测:术前水平的临床意义。
Ann Surg Oncol. 2009 Nov;16(11):3087-93. doi: 10.1245/s10434-009-0625-z. Epub 2009 Jul 23.

引用本文的文献

1
Predicting one-year post-surgical recurrence in colorectal liver metastasis using CT radiomics and machine learning.使用CT影像组学和机器学习预测结直肠癌肝转移术后一年复发情况
PLoS One. 2025 Aug 29;20(8):e0330828. doi: 10.1371/journal.pone.0330828. eCollection 2025.
2
Early Recurrence of Colorectal Liver Metastasis (Number ≤ 5 and Largest Diameter ≤ 3 cm) after Resection or Thermal Ablation: a Multi-center Study of Patterns, Safety, Survival and Risk Factors.结直肠癌肝转移灶切除或热消融术后早期复发(数量≤5个且最大直径≤3 cm):一项关于复发模式、安全性、生存率及危险因素的多中心研究
J Gastrointest Cancer. 2025 Mar 12;56(1):77. doi: 10.1007/s12029-025-01200-4.
3
Predictive model for very early recurrence of patients with perihilar cholangiocarcinoma: a machine learning approach.
肝门部胆管癌患者极早期复发的预测模型:一种机器学习方法
Hepatobiliary Surg Nutr. 2025 Feb 1;14(1):3-15. doi: 10.21037/hbsn-24-385. Epub 2025 Jan 16.
4
Prognostic value of radiologic and pathological response in colorectal cancer liver metastases upon systemic induction treatment: subgroup analysis of the CAIRO5 trial.全身诱导治疗后结直肠癌肝转移患者放射学和病理学反应的预后价值:CAIRO5试验的亚组分析
ESMO Open. 2024 Dec;9(12):104075. doi: 10.1016/j.esmoop.2024.104075. Epub 2024 Dec 11.
5
Clinical impact of very early recurrence after conversion surgery for stage IV gastric cancer.IV期胃癌转化手术后极早期复发的临床影响
Ann Gastroenterol Surg. 2023 Sep 14;8(2):214-220. doi: 10.1002/ags3.12738. eCollection 2024 Mar.
6
Long-term outcomes and early recurrence after resection for metachronous pulmonary metastases from colorectal cancer.结直肠癌术后异时性肺转移切除的长期结果和早期复发。
Langenbecks Arch Surg. 2023 Dec 29;409(1):24. doi: 10.1007/s00423-023-03209-4.
7
Long-term outcomes of staged liver resection for synchronous liver metastases from colorectal cancer and the clinical impact of early recurrence: A single-center retrospective cohort study.结直肠癌同步肝转移分期肝切除的长期预后及早期复发的临床影响:一项单中心回顾性队列研究
Ann Gastroenterol Surg. 2022 Oct 5;7(2):318-325. doi: 10.1002/ags3.12628. eCollection 2023 Mar.
8
A Model to Predict Treatment Failure in Patients Undergoing Upfront Surgery for Resectable Colorectal Liver Metastases.用于预测可切除结直肠癌肝转移患者术前手术治疗失败的模型。
Ann Surg Oncol. 2023 May;30(5):2820-2827. doi: 10.1245/s10434-023-13113-2. Epub 2023 Jan 24.
9
Neoadjuvant chemotherapy improves overall survival in resectable colorectal liver metastases patients with high clinical risk scores-- A retrospective, propensity score matching analysis.新辅助化疗可提高具有高临床风险评分的可切除结直肠癌肝转移患者的总生存率——一项回顾性倾向评分匹配分析。
Front Oncol. 2022 Sep 5;12:973418. doi: 10.3389/fonc.2022.973418. eCollection 2022.
10
Very Early Recurrence After Curative-Intent Surgery for Gastric Adenocarcinoma.胃腺癌根治性手术后的早期复发。
Ann Surg Oncol. 2022 Dec;29(13):8653-8661. doi: 10.1245/s10434-022-12434-y. Epub 2022 Aug 26.